Oppenheimer & Co. Inc. Buys 114,255 Shares of Healthpeak Properties, Inc. $DOC

Oppenheimer & Co. Inc. lifted its stake in Healthpeak Properties, Inc. (NYSE:DOCFree Report) by 518.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 136,291 shares of the real estate investment trust’s stock after acquiring an additional 114,255 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Healthpeak Properties were worth $2,610,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Mather Group LLC. acquired a new position in shares of Healthpeak Properties during the 3rd quarter worth approximately $25,000. City Holding Co. bought a new position in shares of Healthpeak Properties in the third quarter valued at $26,000. Rexford Capital Inc. acquired a new position in Healthpeak Properties during the second quarter worth $28,000. Sound Income Strategies LLC bought a new stake in Healthpeak Properties during the third quarter worth $28,000. Finally, Elevation Point Wealth Partners LLC acquired a new stake in Healthpeak Properties in the second quarter valued at $32,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Trading Down 4.0%

Shares of NYSE:DOC opened at $16.29 on Friday. Healthpeak Properties, Inc. has a 12-month low of $15.71 and a 12-month high of $21.28. The business has a 50 day moving average of $16.79 and a 200-day moving average of $17.55. The company has a quick ratio of 2.82, a current ratio of 2.82 and a debt-to-equity ratio of 1.21. The stock has a market cap of $11.32 billion, a PE ratio of 162.87, a P/E/G ratio of 9.10 and a beta of 1.12.

Healthpeak Properties (NYSE:DOCGet Free Report) last released its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The business had revenue of $719.40 million during the quarter, compared to analysts’ expectations of $685.14 million. During the same period last year, the firm posted $0.46 EPS. The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, equities research analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 7.5%. The ex-dividend date of this dividend is Tuesday, March 17th. Healthpeak Properties’s payout ratio is presently 1,220.00%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Wall Street Zen upgraded shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Saturday, February 7th. Weiss Ratings upgraded Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 26th. Robert W. Baird dropped their price objective on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 12th. Evercore cut their price objective on Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. Finally, Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a report on Monday, January 5th. Six equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties presently has an average rating of “Hold” and an average target price of $19.42.

View Our Latest Stock Report on DOC

About Healthpeak Properties

(Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

See Also

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.